Literature DB >> 3330542

Chromosomal rearrangements, genes, and fragile sites in cancer: clinical and biologic implications.

J J Yunis.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3330542

Source DB:  PubMed          Journal:  Important Adv Oncol        ISSN: 0883-5896


× No keyword cloud information.
  12 in total

1.  Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II.

Authors:  B C Misra; E S Srivatsan
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

2.  A human alpha satellite DNA subset specific for chromosome 12.

Authors:  A Baldini; M Rocchi; N Archidiacono; O J Miller; D A Miller
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

3.  Cytogenetic and in situ DNA-hybridization studies in intracranial tumors of a patient with central neurofibromatosis.

Authors:  B Wullich; M Kiechle-Schwarz; L Mayfrank; W Schempp
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

4.  Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.

Authors:  E S Srivatsan; B C Misra; M Venugopalan; S P Wilczynski
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

5.  Human papillomavirus type 18 DNA is integrated at a single chromosome site in cervical carcinoma cell line SW756.

Authors:  N C Popescu; S C Amsbaugh; J A DiPaolo
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

Review 6.  Cytogenetic abnormalities in cancer: with special emphasis on tumor heterogeneity.

Authors:  S Pathak
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

7.  Oncogenetics. A new emerging field of cancer.

Authors:  R S Verma
Journal:  Mol Gen Genet       Date:  1986-12

8.  Generation of a new adenovirus type 12-inducible fragile site by insertion of an artificial U2 locus in the human genome.

Authors:  Y P Li; R Tomanin; J R Smiley; S Bacchetti
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

9.  The transcriptionally competent U2 gene is necessary and sufficient for adenovirus type 12 induction of the fragile site at 17q21-22.

Authors:  S Gargano; P Wang; E Rusanganwa; S Bacchetti
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

10.  Expression of fragile sites in childhood acute lymphoblastic leukemia patients and normal controls.

Authors:  P N Rao; N A Heerema; C G Palmer
Journal:  Hum Genet       Date:  1988-08       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.